Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
0OE 4-{2-[5-(3-chlorophenyl)-1h-pyrazol-4-yl]-1-[3-(1h-imidazol-1-yl)propyl]-1h-benzimidazol-5-yl}benzoic acid
0OG 3-{5-[3-ethyl-5-(5-methylfuran-2-yl)-1h-pyrazol-1-yl]-1-[(6-oxo-1,6-dihydropyridin-3-yl)methyl]-1h-benzimidazol-2-yl}-4-hydroxybenzoic acid
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 4E92   PDBj   RCSB PDB   PDBe
Header : STRUCTURAL PROTEIN/INHIBITOR
Title : Crystal Structure of the N-Terminal Domain of HIV-1 Capsid in Complex With Inhibitor BM4
Release Data : 2012-04-25
Compound :
mol_id molecule chains
1 Gag protein A,B
fragment: N-terminal domain, UNP residues 133-278
Source :
mol_id organism_scientific expression_system
1 Human immunodeficiency virus 1  (taxid:11676) Escherichia coli  (taxid:562)
gene: gag
Authors : Lemke, C.T.
Keywords : Structural protein Capsid, STRUCTURAL PROTEIN-INHIBITOR complex
Exp. method : X-RAY DIFFRACTION ( 1.800 Å )
Citation :

Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA Protein.

Lemke, C.T.,Titolo, S.,von Schwedler, U.  et al.
(2012)  J.Virol.  86 : 6643 - 6655

PubMed: 22496222
DOI: 10.1128/JVI.00493-12

A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization.

Lemke, C.T.,Titolo, S.,Goudreau, N.  et al.
(2013)  Acta Crystallogr.,Sect.D  69 : 1115 - 1123

PubMed: 23695256
DOI: 10.1107/S0907444913006409

Chain : A, B
UniProt : Q79791 (Q79791_9HIV1)
Reaction : -